Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.

MLA

Hayakawa, Michitaro, et al. “Tocilizumab-Induced Psoriasis-like Eruption Resolved by Shortening the Dose Interval in a Patient with Rheumatoid Arthritis: A Case-Based Review.” Rheumatology International, vol. 39, no. 1, Jan. 2019, pp. 161–66. EBSCOhost, https://doi.org/10.1007/s00296-018-4175-1.

APA

Hayakawa, M., Izumi, K., Higashida-Konishi, M., Ushikubo, M., Tsukamoto, M., Akiya, K., Araki, K., & Oshima, H. (2019). Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review. Rheumatology International, 39(1), 161–166. https://doi.org/10.1007/s00296-018-4175-1

Chicago

Hayakawa, Michitaro, Keisuke Izumi, Misako Higashida-Konishi, Mari Ushikubo, Masako Tsukamoto, Kumiko Akiya, Kazuhiro Araki, and Hisaji Oshima. 2019. “Tocilizumab-Induced Psoriasis-like Eruption Resolved by Shortening the Dose Interval in a Patient with Rheumatoid Arthritis: A Case-Based Review.” Rheumatology International 39 (1): 161–66. doi:10.1007/s00296-018-4175-1.